化浊通脉方对动脉粥样硬化兔胆固醇逆向转运的影响
本文选题:动脉粥样硬化 + 胆固醇逆向转运 ; 参考:《北京中医药大学》2015年博士论文
【摘要】:动脉粥样硬化(AS)是导致心脑血管疾病的重要因素,目前AS引起的心血管疾病(CVD)仍居发达国家人口死亡原因之首。人民寿命的增长,人口老龄化的出现,使得AS发病率、致死率居高不下。因此,对于AS的发病原因、发病机制、预防及治疗措施一直是心血管病研究者的研究热点。AS是由多种因素共同作用引起的多系统参与疾病,作用机制复杂,故而单一作用机制的药物无法起到有效抗AS的作用。中药复方以中医理论为指导,以整体观为主导思想,着眼于宏观、综合治疗,从多角度、多层次、多靶点有效地防治AS,是目前抗AS研究的热点。“脉浊”理论的提出,丰富了中医学对AS病机的认识角度,并将中医学与现代医学相通,化浊通脉法正是针对这一证候所创立,以此为治法的中药复方在前期临床观察中取得了良好的疗效。目的:观察化浊通脉方对AS兔主动脉血管壁AS斑块形成以及对血清和主动脉血管壁细胞内脂质含量的影响,从其影响胆固醇逆向转运(RCT)过程的作用,探讨化浊通脉方抗AS的作用机制。实验方法:健康纯种雄性新西兰大耳白兔40只随机分为4组:空白对照组,模型组,辛伐他汀组,化浊通脉方组(中药复方组)。采用单纯高脂饲料喂养方式制备AS兔模型,分别在给药前及给药14周末禁食后经耳缘静脉采集血液样本,给药15周末经耳缘静脉麻醉后处死动物,取胸主动脉及肝脏样本。肉眼观察各组兔胸主动脉标本脂纹、脂斑形成情况;主动脉标本行HE染色、油红O染色,观察各组兔主动脉壁脂质沉积及斑块形成情况;酶法测定血清中总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)水平;酶联免疫吸附法(ELISA)测定主动脉血管壁细胞内TC、游离胆固醇(FC)水平,肝脏细胞内CD36水平;蛋白印迹法(WB)测定主动脉壁内小凹蛋白-1(cav-1).亲环素A、三磷酸腺苷结合盒转运蛋白Al (ABCA1)、肝脏B类I型清道夫受体(SR-B I)蛋白表达量;实时定量聚合酶链式反应(real-time PCR)测定主动脉壁cav-1 mRNA.亲环素A mRNA、ABCA1 mRNA.肝脏SR-B I mRNA. CD36 mRNA表达量。实验结果:空白对照组兔主动脉血管壁内膜表面光滑,各层结构清晰,内皮细胞完整连续,平滑肌细胞排列整齐紧密有序,无脂质、斑块等沉积;模型组兔主动脉血管壁明显增厚,内皮层脱落,管壁满布脂质、斑块;中药复方组兔主动脉壁内膜稍有增厚,内膜下可见散在泡沫细胞沉积及脂质沉积,未见明显斑块,与辛伐他汀组无明显差异。14周末与空白对照组相比,模型组兔血清中TC、TG、LDL显著升高(P0.01),平滑肌细胞内TC、FC明显升高(P0.05,P0.01);与模型组相比,中药复方组兔血清中TC、TG、LDL明显下降(P0.05,P0.01),主动脉血管壁细胞内TC、FC显著升高(P0.01)。15周末主动脉细胞测定结果显示:与空白对照组相比,模型组兔cav-1蛋白及mRNA表达量显著下降(P0.01);与模型组相比,中药复方组cav-1 mRNA表达量显著增加(P0.01),cav-1蛋白表达量也有增加趋势,但差异无统计学意义(P0.05)。与空白对照组相比,模型组兔亲环素A蛋白表达量明显增加(P0.05),亲环素A mRNA表达量有下降趋势,但差异无统计学意义(P0.05);与模型组相比,中药复方组亲环素A蛋白表达量显著下降(P0.01),亲环素A mRNA表达量显著增加(P0.01)。与空白对照组相比,模型组兔ABCA1蛋白表达量有下降趋势,但差异无统计学意义(P0.05),ABCA1 mRNA表达量显著增加(P0.01);与模型组相比,中药复方组ABCA1蛋白表达量有增加趋势,但差异无统计学意义P0.05), ABCA1 mRNA表达量显著下降(P0.01)。肝细胞测定结果显示:与空白对照组相比,模型组兔SR-B I蛋白及mRNA表达量有下降趋势,但差异无统计学意义(P0.05);与模型组相比,中药复方组SR-B I mRNA表达量有增加趋势,但差异无统计学意义(P0.05)。与空白对照组相比,模型组兔CD36蛋白表达量有增加趋势,但差异无统计学意义P0.05), CD36 mRNA表达量明显增加(P0.05);与模型组相比,中药复方组CD36蛋白表达量有减少趋势,但差异无统计学意义(P0.05)。结论:1.化浊通脉方能够抑制AS兔主动脉血管内膜增生,减少内皮下泡沫细胞的形成及脂质沉积,从而减少AS斑块形成。2.化浊通脉方可有效降低AS兔血清TC、TG、LDL水平,显著降低AS兔主动脉血管壁细胞内TC、FC含量。3.化浊通脉方能够通过提高cav-1蛋白及基因水平、亲环素A的基因水平,促进细胞内胆固醇转运复合体生成,对ABCA1蛋白表达量有上调作用趋势,促进细胞内胆固醇流出,保障cav-1、亲环素A的正常表达,减少斑块中亲环素A的过度表达,最终达到抗AS的作用。4.化浊通脉方能够通过对肝脏SR-B I基因水平有一定的上调作用趋势、对CD36蛋白表达有一定的抑制作用趋势,可能促进血中胆固醇被肝脏选择性摄取、代谢,使脂质顺利代谢,最终达到抗AS的作用。
[Abstract]:Atherosclerosis (AS) is an important factor leading to cardiovascular and cerebrovascular diseases. At present, the cardiovascular disease (CVD) caused by AS is still the first cause of death in the developed countries. The growth of the people's life and the emergence of the aging population make the incidence of AS and death rate high. Therefore, the causes, pathogenesis, prevention and treatment measures for the pathogenesis of AS are made. The research hotspot of cardiovascular disease researchers.AS is a multi system involved in disease caused by a variety of factors. The mechanism is complex, so the single action mechanism can not play an effective anti AS effect. Chinese medicine compound is guided by the theory of traditional Chinese medicine, guided by the concept of holism, focusing on macroscopical, comprehensive treatment, from multi angle. Degree, multi-level and multi target effectively prevent and cure AS, is the hot spot of anti AS research at present. "Pulse turbid" theory has enriched the understanding angle of Chinese medicine to AS pathogenesis, and interlinked the traditional Chinese medicine with modern medicine. Objective: To observe the effect of Hua Zhuo Tong Mai Recipe on the formation of AS plaque in the aorta wall of AS rabbit and the lipid content in the blood serum and aorta wall cells, and to explore the mechanism of anti AS in the process of RCT. The method of actual test: healthy pure breed male New Zealand white rabbit 40 Only 4 groups were randomly divided into 4 groups: blank control group, model group, simvastatin group, turbid Tongmai prescription group (Chinese medicine compound group). The rabbit model was prepared by feeding simple high fat diet. The blood samples were collected before and after the 14 weekend fasting, and the animals were killed after the ear vein anesthesia at the end of the 15 week and the thoracic aorta was taken for the 15 week. The lipid profiles and formation of fat spots in the thoracic aorta of rabbits were observed by the naked eye. The lipid deposition and plaque formation of aorta wall in each group were observed by HE staining and oil red O staining. The serum total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL) were measured by enzyme method. Enzyme-linked immunosorbent assay (ELISA) was used to determine the intracellular TC, free cholesterol (FC) level, CD36 level in the liver cells, and Western blot (WB) for the determination of -1 (Cav-1) in the aortic wall. The expression of cyclophilin A, adenosine triphosphate binding cassette transporter Al (ABCA1), and liver B I type scavenger receptor (Cav-1) protein expression; The quantitative polymerase chain reaction (real-time PCR) was used to determine the Cav-1 mRNA. Pro cyclophilin A mRNA of the aortic wall and the SR-B I mRNA. CD36 expression of the ABCA1 mRNA.. The experimental results showed that the intima surface of the aorta wall of the rabbit aorta was smooth, the structure of each layer was clear, the endothelial cells were complete and continuous, the smooth muscle cells were arranged neatly and orderly, without lipid. In the model group, the aorta wall of the rabbit aorta was thickened obviously, the endothelial layer fell off, the wall of the tube was covered with lipid and plaque. The intima of the aorta was slightly thickened in the compound group of Chinese medicine, and the deposition of foam cells and lipid deposition were found under the intima, and there was no obvious plaque in the intima. The.14 weekend was compared with the blank control group, compared with the blank control group. The serum levels of TC, TG and LDL in the rabbit serum were significantly increased (P0.01), and TC and FC in the smooth muscle cells were significantly increased (P0.05, P0.01). Compared with the model group, the serum TC, TG, LDL in the rabbit serum of the Chinese medicine compound group decreased significantly (P0.05, P0.01), and the aortic vascular wall cells in the aorta were significantly higher than those in the blank control group. The expression of Cav-1 protein and mRNA in the model group decreased significantly (P0.01). Compared with the model group, the expression of Cav-1 mRNA in the compound group of Chinese medicine increased significantly (P0.01), and the expression of Cav-1 protein also increased, but the difference was not statistically significant (P0.05). Compared with the blank control group, the expression of cyclophilin A protein in the model group was significantly increased (P0.05), pro ring. There was no significant difference in the expression of A mRNA, but there was no significant difference (P0.05). Compared with the model group, the expression of Pro cyclophilin A protein decreased significantly (P0.01), and the expression of cyclophilin A mRNA increased significantly (P0.01). Compared with the blank control group, the expression of ABCA1 protein in the model group had a downward trend, but the difference was not statistically significant (P0.0). (P0.0, the difference was not statistically significant (P0.0). 5), the expression of ABCA1 mRNA increased significantly (P0.01). Compared with the model group, the expression of ABCA1 protein in the Chinese medicine compound group increased, but the difference was not statistically significant P0.05), and the expression of ABCA1 mRNA decreased significantly (P0.01). The results of hepatocyte determination showed that the expression of SR-B I protein and mRNA in the model group had a decreasing trend compared with the blank control group. But the difference was not statistically significant (P0.05). Compared with the model group, the expression of SR-B I mRNA in the Chinese medicine compound group increased, but the difference was not statistically significant (P0.05). Compared with the blank control group, the expression of CD36 protein in the model group was increased, but the difference was not statistically significant P0.05), CD36 mRNA expression increased significantly (P0.05); and the model of the model group (P0.05); The expression of CD36 protein in the Chinese medicine compound group decreased, but the difference was not statistically significant (P0.05). Conclusion: 1. Hua Tong Mai Fang can inhibit the intima hyperplasia of aorta in AS rabbit, reduce the formation of the foam cells under the endothelium and the lipid deposition, and reduce the form of AS plaques form.2. turbid and Tongmai, which can effectively reduce the TC, TG, LDL in the serum of AS rabbit. Level, significantly reduced TC in AS rabbit aortic vascular wall cells, FC content.3. turbid pulse can improve the level of Cav-1 protein and gene, the gene level of cyclophilin A, promote the formation of intracellular cholesterol transport complex, the upward trend of the expression of ABCA1 protein, promote intracellular cholesterol outflow, guarantee Cav-1, and procyclin A Normal expression, reduce the overexpression of cyclophilin A in plaque, and finally achieve the anti AS effect of.4. turbid vein, which can have a certain trend of up regulation of the liver SR-B I gene, and can inhibit the expression of CD36 protein, which may promote the selective uptake and metabolism of cholesterol in the liver and the smooth metabolism of the lipid. Finally, the effect of anti AS is achieved.
【学位授予单位】:北京中医药大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R285.5
【相似文献】
相关期刊论文 前10条
1 王景春;丁平;杜信宏;;化栓通脉丸治疗高血脂症的临床观察[J];中国实用医药;2006年02期
2 张大创;吴泽铭;陈鹏毅;邢洁;;通脉消斑Ⅰ号治疗颈动脉粥样硬化斑块临床观察[J];中国中医急症;2009年03期
3 蔡焦生;卢建香;杨树明;;通脉复明饮治疗视网膜中央静脉阻塞疗效观察[J];中国民间疗法;2009年10期
4 徐寒松;孔德明;向慧;;通脉糖眼明胶囊对糖尿病视网膜病变患者血管内皮生长因子水平的影响[J];第三军医大学学报;2011年13期
5 汪庆平;陈自权;杨华有;;消栓通脉丸治疗血栓闭塞性脉管炎——99例疗效观察[J];中医药研究;1990年04期
6 袁丽华,李武祥,刘天军;通脉酯治疗脑供血不全70例疗效观察[J];医学理论与实践;2002年05期
7 丛军波,刘丽娜;宣痹通脉饮治疗冠心病40例[J];中国民间疗法;2005年09期
8 钱冠清;黄媚娥;韦多;;“通脉灵”对微血管生长影响的研究[J];天津中医;1987年03期
9 杨凤梅;熊永爱;侯莉伟;黄晶;王念明;杨明;;通脉口服液提取工艺变更及药理试验验证[J];中国实验方剂学杂志;2013年20期
10 梁兆松;;祛淤通脉三圣药[J];养生大世界;2006年12期
相关会议论文 前10条
1 胡胜利;梅燕琴;;以透骨通脉饮(自拟)为主治疗糖尿病足的研究附:600例临床报告[A];中华中医药学会周围血管病分会第四届学术大会暨中华中医药学会周围血管病分会25年会庆论文集[C];2011年
2 许立;袁冬平;张良;方泰惠;蒋宝平;周玲玲;;大黄对降糖通脉颗粒治疗肾衰作用的影响[A];2007年全国药物毒理学会议论文集[C];2007年
3 胡胜利;梅燕琴;;透骨通脉饮(自拟)治疗下肢深静脉血栓形成综合征的临床研究附:360例临床报告[A];全国中西医结合周围血管病专题研讨会论文汇编[C];2005年
4 关崧;赵翠芳;柴铁玲;彭继升;;温经通脉方外洗治疗糖尿病下肢血管病变的临床研究[A];第九次全国中医糖尿病学术大会论文汇编[C];2006年
5 徐寒松;孔德明;李雪梅;王明强;赵胜;;通脉糖眼明胶囊治疗单纯型糖尿病视网膜病变临床研究[A];贵州省中西医结合学会第一次内分泌代谢学术会议论文汇编[C];2006年
6 张肇域;张葆惠;范海平;;《通脉灵》《溶栓灵》治疗血栓闭塞性脉管炎[A];中国中医药学会建会20周年学术年会专辑(下)[C];1999年
7 王硕仁;周波;赵怡茹;秦腊梅;董安铭;;降压通脉Ⅱ号方逆转高血压病左室肥厚及颈动脉重塑的研究[A];第五次全国中西医结合血瘀证及活血化瘀研究学术大会论文汇编[C];2001年
8 林小东;张柄才;管子函;;透骨通脉饮治疗糖尿病下肢动脉硬化闭塞症的临床疗效观察[A];浙江省中医药学会第二届“之江中医药论坛”暨2012年学术年会文集[C];2012年
9 黄献平;袁肇凯;陈清华;简维维;莫莉;孙桂香;胡志希;;养心通脉方主要与次要有效部位交互作用抗心肌缺血的研究[A];中华中医药学会中医诊断学分会第十次学术研讨会论文集[C];2009年
10 关崧;赵翠芳;柴铁玲;彭继升;;温经通脉方外洗治疗糖尿病下肢血管病变的临床研究[A];中华中医药学会内科分会消渴病第五届学术研讨会论文集[C];2006年
相关重要报纸文章 前9条
1 ;通脉降压系列方降压效果显著[N];中国中医药报;2004年
2 林翠茹;“注射用通脉”有独特优势[N];中国中医药报;2005年
3 ;冰蛹通脉含片[N];中国中医药报;2003年
4 本报记者 王海洋;万隆制药的“通脉”期待[N];医药经济报;2005年
5 记者周颖;通脉强肾中药新科技示范项目启动[N];中国中医药报;2003年
6 河南省荥阳市中医院 韩文刚;通脉化滞除眩晕[N];中国中医药报;2012年
7 河南省中医学院一附院 崔炎 刘辉 吴建萍;通脉丸治雷诺综合征[N];中国中医药报;2014年
8 王林;“速效通脉”法治疗脉管炎[N];光明日报;2000年
9 江苏省新沂市委书记 赵立群;集体经济为贫困村“造血通脉”[N];光明日报;2014年
相关博士学位论文 前10条
1 董建勋;通脉宁防治经皮腔内血管成形术后再狭窄细胞分子机制的研究[D];北京中医药大学;2004年
2 朱智德;养心通脉方对异丙肾上腺素心衰大鼠防治机理的研究[D];湖北中医药大学;2012年
3 李晓庆;解毒通脉方对糖尿病足溃疡内皮垞细胞的干预作用及其机制的探讨[D];北京中医药大学;2015年
4 陈清华;心血瘀阻证心肌血管新生及其养心通脉有效部位方干预效应的研究[D];湖南中医药大学;2008年
5 赵代鑫;通脉口服液延缓肾纤维化的临床和实验研究[D];广州中医药大学;2005年
6 冷伟;肾小管间质损害的中医证候研究及通脉口服液的干预作用[D];广州中医药大学;2008年
7 范萍;益气活血中药复方通脉口服液干预DN的疗效观察及肾保护作用研究[D];广州中医药大学;2007年
8 陈小睿;通脉醒脑滴丸抗脑缺血的药效及机理研究[D];成都中医药大学;2008年
9 孙晴;动脉粥样硬化脂质斑块形成评估及调脂通脉颗粒作用机制研究[D];北京中医药大学;2014年
10 王晓宁;化浊通脉方对动脉粥样硬化兔胆固醇逆向转运的影响[D];北京中医药大学;2015年
相关硕士学位论文 前10条
1 张卫娜;通脉颗粒治疗高同型半胱氨酸血症的临床研究[D];福建中医学院;2008年
2 郑庆忠;通脉颗粒对慢性高血压性视网膜病变的干预研究[D];福建中医药大学;2011年
3 杨凤梅;通脉制备工艺的再评价及相应颗粒剂成型研究[D];成都中医药大学;2014年
4 图雅;通脉灵胶囊的研究[D];山东中医药大学;2005年
5 牟宗平;丹芪通脉饮治疗2型糖尿病下肢血管病变的临床研究[D];山东中医药大学;2010年
6 卢巧喜;通脉益智颗粒治疗血管性痴呆的作用机制研究[D];南京中医药大学;2014年
7 翟学佳;通脉方质量评价方法及药动学研究[D];浙江大学;2007年
8 唐媛媛;芪生通脉方对2型糖尿病下肢血管病变相关因素的影响与分析[D];湖北中医学院;2009年
9 程广清;化瘀通脉方治疗颈动脉粥样硬化斑块的临床研究[D];山东中医药大学;2014年
10 杨波;稳糖通脉颗粒治疗糖尿病血管病变的实验研究[D];山东中医药大学;2006年
,本文编号:1842566
本文链接:https://www.wllwen.com/yixuelunwen/mazuiyixuelunwen/1842566.html